Clinical Trial Update: Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the maximum tolerated dose of vandetanib when given with whole brain radiotherapy in patients with non-small cell lung cancer and br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Vandetanib (Caprelsa) (vandetanib)

Snippet

Sponsor: Sanofi | Conditions: Non-small Cell Lung Cancer (NSCLC) | Phase 1 | Status: TERMINATED